RecruitingNCT05593081
Multicenter Study of Fulminant Type 1 Diabetes in China
Sponsor
Second Xiangya Hospital of Central South University
Enrollment
240 participants
Start Date
May 20, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
This study took FT1D（fulminant type 1 diabetes） as the research object, collected the cases of FT1D patients, and described the clinical characteristics of this type of disease. The HLA susceptibility genes of FT1D were identified by PCR and other techniques, taking age-sex-matched healthy subjects as controls and HLA genes as the research entry point.
Eligibility
Inclusion Criteria2
- patients with fulminant 1 diabetes
- \) diabetic ketosis or ketoacidosis occurred soon after the onset of hyperglycemic symptoms; 2) patient presented with plasma glucose ≥16.0 mmol/L and HbA1c \<8.7% at the first visit; and 3) patient had urinary C-peptide excretion \<10 µg/day,fasting serum C-peptide level \<0.10 nmol/L, or postprandial serum C-peptide \<0.17 nmol/L at onset
Exclusion Criteria2
- Case reports of previously diagnosed with diabetes were excluded.
- Healthy Volunteers
Interventions
GENETICHLA
Distinguish based on clinical features
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05593081
Related Trials
Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
NCT065038091 location
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
NCT038353121 location
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
NCT0478626229 locations
Genetics Of Autoimmunity In Type I Diabetes
NCT036489181 location
Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery
NCT074782111 location